Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Potassium Channel
    (2)
  • ATPase
    (1)
  • Apoptosis
    (1)
  • Endogenous Metabolite
    (1)
  • PPAR
    (1)
  • Phosphatase
    (1)
  • p38 MAPK
    (1)
  • Others
    (5)
Filter
Search Result
Results for "

hypoglycaemic

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • Natural Products
    3
    TargetMol | Natural_Products
Managlinat dialanetil
MB06322, MB 6322, CS-917
T16009L280782-97-0In house
Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes.
  • Inquiry Price
Size
QTY
Mitiglinide calcium hydrate
KAD-1229 calcium hydrate, S-21403 calcium hydrate
T1530207844-01-7
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
1,3-BUTANEDIOL
T9257107-88-0
1,3-Butanediol (BD) is a ketogenic substance. Ketone bodies are essential energy substrates in the absence of exogenous nutrients, and more recently, they have been suggested to prevent disease and improve longevity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Mitiglinide Calcium
KAD-1229, S21403
T6587145525-41-3
Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
CS476
NSC302998
T1501341177-35-9
CS476 is a potent drug of hypoglycaemic.
  • Inquiry Price
6-8 weeks
Size
QTY
Ciglitazone
U-63287, U 63287, Ciglitazona, ADD-3878, ADD3878, ADD 3878
T1971074772-77-3
Ciglitazone (ADD 3878) is a potent and selective PPARγ agonist (EC50: 3 μM) and oral hypoglycemic agent. Ciglitazone inhibits proliferation and differentiation of th17 cells, decreases insulin levels, vascular endothelial growth factor production and blood pressure, and induces cell cycle arrest in gastric cancer cells. Selegiline induces apoptosis in opossum kidney epithelial cells and activates nuclear translocation of p38 MAPK and apoptosis-inducing factor (AIF). Ciglitazone exhibits hypoglycaemic activity in animal models of obesity and hyperglycaemia.
  • Inquiry Price
6-8 weeks
Size
QTY
Cadisegliatin
T62821859525-02-3
Cadisegliatin (TTP-399) is a liver-selective glucose kinase (GK) activator with hypoglycemic effects, useful for studying type 2 diabetes.
  • Inquiry Price
7-10 days
Size
QTY
AZ-DF 265
T6860283901-40-0
AZ-DF 265 is a hypoglycaemic drug which stimulates insulin release. AZ-DF-265 inhibits ATP-sensitive potassium channels and displaces [3H]-glibenclamide from the sulphonylurea receptor.
  • Inquiry Price
6-8 weeks
Size
QTY
Momordicoside L
TN194681348-83-6
Momordicoside L has hypoglycaemic antihyperglycaemic activities.
  • Inquiry Price
Size
QTY
Globularin
TN41381399-49-1
Globularin has hypoglycaemic and hypolipidemic activities in normal and streptozotocin-induced diabetic rats.
  • Inquiry Price
Size
QTY